Mayukh Dealtrade [MAYUKH] vs Entero Healthcare [ENTERO] Detailed Stock Comparison
Mayukh Dealtrade
BSE
Loading...
Entero Healthcare
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Mayukh Dealtrade wins in 10 metrics, Entero Healthcare wins in 7 metrics, with 1 ties. Mayukh Dealtrade appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Mayukh Dealtrade | Entero Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 56.25 | 49.64 | Entero Healthcare |
| Price-to-Book Ratio | 0.88 | 2.95 | Mayukh Dealtrade |
| Debt-to-Equity Ratio | 0.00 | 21.76 | Mayukh Dealtrade |
| PEG Ratio | -0.69 | 1.30 | Mayukh Dealtrade |
| EV/EBITDA | 22.44 | 26.36 | Mayukh Dealtrade |
| Profit Margin (TTM) | 70.91% | 1.90% | Mayukh Dealtrade |
| Operating Margin (TTM) | 43.51% | 2.94% | Mayukh Dealtrade |
| EBITDA Margin (TTM) | 43.51% | 2.94% | Mayukh Dealtrade |
| Return on Equity | 5.36% | 5.36% | Tie |
| Return on Assets (TTM) | 5.18% | 3.51% | Mayukh Dealtrade |
| Free Cash Flow (TTM) | $-27.01M | $-881.80M | Mayukh Dealtrade |
| 1-Year Return | -26.42% | -17.14% | Entero Healthcare |
| Price-to-Sales Ratio (TTM) | 12.16 | 0.94 | Entero Healthcare |
| Enterprise Value | $433.27M | $51.35B | Entero Healthcare |
| EV/Revenue Ratio | 12.19 | 0.95 | Entero Healthcare |
| Gross Profit Margin (TTM) | 62.49% | 9.94% | Mayukh Dealtrade |
| Revenue per Share (TTM) | $0 | $1,242 | Entero Healthcare |
| Earnings per Share (Diluted) | $0.01 | $23.55 | Entero Healthcare |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Mayukh Dealtrade vs Entero Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Mayukh Dealtrade | 10.39% | -4.88% | -8.24% | -30.36% | -21.21% | -39.53% |
| Entero Healthcare | 1.40% | -5.30% | -10.01% | -2.28% | -1.16% | -21.13% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Mayukh Dealtrade | -26.42% | -22.00% | 18.18% | 1.30% | 1.30% | 1.30% |
| Entero Healthcare | -17.14% | -1.50% | -1.50% | -1.50% | -1.50% | -1.50% |
News Based Sentiment: Mayukh Dealtrade vs Entero Healthcare
Mayukh Dealtrade
News based Sentiment: MIXED
September presented a complex narrative for Mayukh Dealtrade (Sattva Sukun Lifecare), with a notable share price increase countered by negative analyst sentiment and concerns about financial performance. The company's strategic moves, like the acquisition, are overshadowed by a lack of transparency, creating a mixed outlook for investors.
Entero Healthcare
News based Sentiment: MIXED
Entero Healthcare Solutions is demonstrating strong financial performance with impressive revenue and profit growth, as evidenced by the Q2 FY25 and Q1 FY26 results. However, the stock has experienced significant volatility and a decline over the past six months, creating a mixed investment picture. The upcoming investor meetings and Q3 2026 earnings report will be crucial to watch.
Performance & Financial Health Analysis: Mayukh Dealtrade vs Entero Healthcare
| Metric | MAYUKH | ENTERO |
|---|---|---|
| Market Information | ||
| Market Cap | ₹432.00M | ₹49.85B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 750,350 | 106,975 |
| 90 Day Avg. Volume | 741,691 | 83,414 |
| Last Close | ₹0.85 | ₹1,148.20 |
| 52 Week Range | ₹0.64 - ₹1.65 | ₹1,080.00 - ₹1,584.25 |
| % from 52W High | -48.48% | -27.52% |
| All-Time High | ₹6.86 (Oct 11, 2021) | ₹1,584.25 (Nov 04, 2024) |
| % from All-Time High | -87.61% | -27.52% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.25% | 0.28% |
| Quarterly Earnings Growth | 0.29% | 0.38% |
| Financial Health | ||
| Profit Margin (TTM) | 0.71% | 0.02% |
| Operating Margin (TTM) | 0.44% | 0.03% |
| Return on Equity (TTM) | 0.05% | 0.05% |
| Debt to Equity (MRQ) | 0.00 | 21.76 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹1.25 | ₹396.70 |
| Cash per Share (MRQ) | N/A | ₹73.09 |
| Operating Cash Flow (TTM) | ₹-28,984,000 | ₹-1,784,990,000 |
| Levered Free Cash Flow (TTM) | ₹11.90M | ₹948.20M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Mayukh Dealtrade vs Entero Healthcare
| Metric | MAYUKH | ENTERO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 56.25 | 49.64 |
| Forward P/E | N/A | 22.40 |
| PEG Ratio | -0.69 | 1.30 |
| Price to Sales (TTM) | 12.16 | 0.94 |
| Price to Book (MRQ) | 0.88 | 2.95 |
| Market Capitalization | ||
| Market Capitalization | ₹432.00M | ₹49.85B |
| Enterprise Value | ₹433.27M | ₹51.35B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 12.19 | 0.95 |
| Enterprise to EBITDA | 22.44 | 26.36 |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | ₹1.25 | ₹396.70 |
Financial Statements Comparison: Mayukh Dealtrade vs Entero Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MAYUKH | ENTERO |
|---|---|---|
| Revenue/Sales | ₹19.55M | ₹14.04B |
| Cost of Goods Sold | ₹7.34M | ₹12.64B |
| Gross Profit | ₹12.22M | ₹1.40B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹9.63M | ₹412.02M |
| EBITDA | ₹10.57M | ₹558.96M |
| Pre-Tax Income | ₹9.53M | ₹363.63M |
| Income Tax | ₹2.60M | ₹61.31M |
| Net Income (Profit) | ₹6.92M | ₹302.32M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MAYUKH | ENTERO |
|---|---|---|
| Cash & Equivalents | ₹1.91M | ₹2.29B |
| Total Current Assets | ₹123.15M | ₹20.76B |
| Total Current Liabilities | ₹14.10M | ₹8.45B |
| Long-Term Debt | N/A | ₹670.18M |
| Total Shareholders Equity | ₹231.51M | ₹17.70B |
| Retained Earnings | N/A | ₹638.28M |
| Property, Plant & Equipment | ₹13.57M | ₹1.64B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MAYUKH | ENTERO |
|---|---|---|
| Operating Cash Flow | ₹-8.91M | N/A |
| Capital Expenditures | ₹-10.80M | N/A |
| Free Cash Flow | ₹-19.12M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MAYUKH | ENTERO |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 750,350 | 106,975 |
| Average Daily Volume (90 Day) | 741,691 | 83,414 |
| Shares Outstanding | 192.00M | 43.51M |
| Float Shares | N/A | 11.24M |
| % Held by Insiders | N/A | 0.63% |
| % Held by Institutions | N/A | 0.21% |
Dividend Analysis & Yield Comparison: Mayukh Dealtrade vs Entero Healthcare
| Metric | MAYUKH | ENTERO |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |